Logo image
Differential expression of immune factor between patients with chronic prostatitis/chronic pelvic pain syndrome and the healthy volunteers
Journal article   Peer reviewed

Differential expression of immune factor between patients with chronic prostatitis/chronic pelvic pain syndrome and the healthy volunteers

Chen Ye, Guang'an Xiao, Jian Xu, Shengfei Qin, Yuhua Luo, Guanghua Chen, H. Henry Lai and Tie Zhou
International urology and nephrology, Vol.50(3), pp.395-399
03/01/2018
DOI: 10.1007/s11255-017-1763-z
PMID: 29235061

View Online

Abstract

Purpose Immune mechanisms have been hypothesized to contribute to the development of CP/CPPS. In this study, we investigated the differential expression of immune factors between patients with CP/CPPS and healthy volunteers. Methods This study was registered in Australian New Zealand Clinical Trials Registry. Healthy volunteers and patients with CP/CPPS were enrolled in this study. The inclusion criteria for patients were below: (1) aged 18-45 years old; (2) prostatitisrelated syndrome longer than 3 months; (3) normal routine urine culture and negative bacterial culture in prostatic fluid. Patients were further classified into two groups: types IIIA and IIIB CP/CPPS according to the results of EPS routine test. Serum immune markers include IgA, IgM, IgG, -CD4+ and -CD8+. Results There are total 23 CP/CPPS patients, including 12 type IIIB and 11 type IIIA. Relatively, there are 26 healthy volunteers. The serum levels of IgG were higher in CP/CPPS patients compared to healthy volunteers (1141.2 +/- 204.3 vs 1031.9 +/- 173.7 mg/L, p = 0.045), while the serum levels of -CD8+ were lower in CP/CPPS patients compared to healthy volunteers (492.8 +/- 185.6 vs 640.0 +/- 246.8 cells/mu L, p = 0.021). Furthermore, serum levels of IgG were higher in patients with IIIA CP/CPPS compared to those with IIIB (1244.3 +/- 151.6 vs 1054.3 +/- 209.3 mg/L, p = 0.023). Conclusions Differential levels of IgG and -CD8+ between CPPS patients and healthy volunteers suggest a contributing role of immune mechanisms to the development of CP/CPPS; and IgG may play an important role in inflammatory CPPS. Clinical Study registration number ACTRN12613000792729.
Life Sciences & Biomedicine Science & Technology Urology & Nephrology

Details

Metrics

Logo image